Anika Therapeutics, Inc.
ANIK· Nasdaq
ANIKAnika Therapeutics, Inc.
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Revenue | $34.29M | $35.40M | $24.72M | $21.26M |
| Net Income | $2.84M | $5.79M | $4.51M | -$6.69M |
| EPS Diluted | $0.20 |
Anika Therapeutics, Inc. · CIK 898437 · Engraved from SEC EDGAR
| $0.40 |
| $0.31 |
| -$0.46 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
